Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-251501
Filing Date
2024-11-06
Accepted
2024-11-06 06:01:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d910109dsc13ga.htm SC 13G/A 37261
  Complete submission text file 0001193125-24-251501.txt   38897
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93313 | Film No.: 241429051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10 QUEEN STREET PLACE LONDON X0 EC4R 1BE
Business Address 10 QUEEN STREET PLACE LONDON X0 EC4R 1BE 07767686326
St George Street Capital (Filed by) CIK: 0001994960 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G/A